logo
Select company
Select metric
$ -14.61MConsolidated Income
VS
Market
32
Sector
61
Industry
75
History
60
$ 1.06Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information

Ticker

MRKR

Company Name

MARKER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARKER THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRKR - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -14.61M
3/31/2025$ -12.78M
12/31/2024$ -10.73M
9/30/2024$ -9.7M
6/30/2024$ -10.37M
3/31/2024$ -5.66M
12/31/2023$ -8.24M
9/30/2023$ -9.29M
6/30/2023$ -13.23M
3/31/2023$ -24.99M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -25.28M.
  • Over the past 5 years, MARKER THERAPEUTICS INC's average Cons. Inc. has been $ -23.64M.
  • The median Cons. Inc. for MARKER THERAPEUTICS INC during this period was $ -25.13M
  • MARKER THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -5.66M.
  • The lowest Cons. Inc. recorded by MARKER THERAPEUTICS INC in the same timeframe $ -43.01M

MARKER THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
LPCN : LIPOCINE INC $ -4.51MBOLT : BOLT BIOTHERAPEUTICS INC $ -50.71MXAIR : BEYOND AIR INC $ -43.5MTRAW : TRAWS PHARMA INC $ -17.82MINM : INMED PHARMACEUTICALS INC $ -8.16MLGVN : LONGEVERON INC $ -18.54MLEXX : LEXARIA BIOSCIENCE CORP $ -11.4MNBY : NOVABAY PHARMACEUTICALS INC $ 3.32MNRXS : NEURAXIS INC $ -7.17MIBIO : IBIO INC $ -18.38M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

MRKR - Consolidated Income, Last 5 years

$ -43.01M

Minimum

Mar 31, 2022

$ -5.66M

Maximum

Mar 31, 2024

$ -23.64M

Average

$ -25.13M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M